S A Fuqua1, D C Allred, R J Auchus
1University of Texas Health Science Center, Department of Medicine, San Antonio 78284.
Estrogen receptor (ER) variants, like the exon 5 variant, may drive antiestrogen resistance in breast cancer. Their expression levels alongside wild-type ER influence treatment response and metastasis.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: